[SY01] Asthma- Session Title : Optimal asthma care |
Crystal Ballroom 1 | |
---|---|---|
10:30-12:00 | Chair: Ho Joo Yoon(Hanyang University)Jung Hyun Chang(Ewha Womans University) | |
10:30-11:00 | Novel treatment strategies for mild asthma | Yeon-Mok Oh(University of Ulsan) |
11:00-11:30 | Optimal selection of inhalers in asthma | YONG IL HWANG(Hallym University) |
11:30-12:00 | Non-T2 asthma: approach and management | Ji-yong MOON(Hanyang University) |
[SY02] Asthma– Session Title : Precision medicine in asthma treatment |
Crystal Ballroom 1 | |
13:30-15:00 | Chair: Hisako Matsumoto(Kyoto University Graduate School of Medicine)Yong Chul Lee(Chonbuk National University) | |
13:30-14:00 | Moving toward precision medicine in severe difficult asthma; a role of serum periostin | Hisako Matsumoto(Kyoto University Graduate School of Medicine) |
14:00-14:30 | Pharmacogenomics in asthma treatment | Heung-Woo Park(Seoul National University) |
14:30-15:00 | Treatment of severe asthma based on treatable traits | Mi-Ae Kim(CHA University) |
[SY03] Environmental Lung Disease- Session Title: Hot issues in environmental lung disease in 2019 |
Crystal Ballroom 1 | |
15:30-17:00 | Chair: HyoungKyu Yoon(The Catholic University of Korea)Sung Hwan Jeong(Gachon University) | |
15:30-16:00 | Impact of air pollution on lung function and imaging phenotypes | Woo Jin Kim(Kangwon University) |
16:00-16:30 | Screening for asbestos-related lung cancer | HyoungKyu Yoon(The Catholic University of Korea) |
16:30-17:00 | Humidifier-disinfectants related asthma | Jongmin Lee(The Catholic University) |
[SY04] Pulmonary Vascular Disease- Session Title: Updated management of VTE |
Crystal Ballroom 2 | |
10:30-12:00 | Chair: Sang-Do Lee(University of Ulsan)Byoung Whui Choi(Chung-Ang University) | |
10:30-11:00 | Is it possible to use DOACs in patients with VTE and CRF on HD? | Hun Gyu Hwang(Soonchunhyang University) |
11:00-11:30 | Who would be candidate for long-term management of DOACs? | Yee Hyung Kim(Kyung Hee University) |
11:30-12:00 | Clinical practices to detect and to manage patients with antiphospholipid syndrome and VTE | Yong Sub Na(Chosun University) |
[SY05] ILD- Session Title: Update in the management of IPF |
Crystal Ballroom 2 | |
13:30-15:00 | Chair: Moo Suk Park(Yonsei University)Luca Richeldi(Universita Cattolica del Sacro Cuore) | |
13:30-14:00 | Diagnosis & Treatment of IPF : when to start and when to stop antifibrotics | Hye Sook Choi(Kyung Hee University) |
14:00-14:30 | New emerging phamacological treatment for IPF | Luca Richeldi(Universita Cattolica del Sacro Cuore) |
14:30-15:00 | Acute Exacerbation of IPF: current management and future perspectives | Jin Woo Song(University of Ulsan) |
[SY06] ILD- Session Title: Progressive fibrosing ILD beyond IPF |
Crystal Ballroom 2 | |
15:30-17:00 | Chair: Arata Azuma(Pulmonary Medicine, Nippon Medical School)Sadatomo Tasaka(Hirosaki University School of Medicine) | |
15:30-16:00 | Non-IPF fibrosing ILD | Arata Azuma(Pulmonary Medicine, Nippon Medical School) |
16:00-16:30 | Recent advances in the diagnosis and management of Pneumocystis pneumonia | Sadatomo Tasaka(Hirosaki University School of Medicine) |
16:30-17:00 | Diagnosis and management of patients with CTD-ILD: A single-center experience | Yong Hyun Kim(The Catholic University) |
[SY07] Bronchoscopy- Session Title: Endoscopic modalities in chest medicine |
Crystal Ballroom 3 | |
10:30-12:00 | Chair: Ho Joong Kim(Sungkyunkwan University)Young Kyoon Kim(The Catholic University) | |
10:30-11:00 | Medical thoracoscopic management in pleural diseases | Young Sik Park(Seoul National University) |
11:00-11:30 | EBUS-TBNA and EUS-B; update | Bin Hwangbo (National Cancer Center) |
11:30-12:00 | Bronchoscopic management for emphysema and severe asthma; practical issues and case selection | Sei Won Lee(University of Ulsan) |
[SY08] Lung Cancer- Session Title: Coping with ALK rearranged NSCLC |
Crystal Ballroom 3 | |
13:30-15:00 | Chair: Takashi Seto(National Hospital Organization Kyushu Cancer Center)Kye Young Lee(Konkuk University) | |
13:30-14:00 | What is the best long-term treatment plan for ALK rearranged NSCLC? | Takashi Seto(National Hospital Organization Kyushu Cancer Center) |
14:00-14:30 | Molecular resistance mechanisms of ALK inhibitors | Seung Hyeun Lee(Kyung Hee University) |
14:30-15:00 | Optimal treatment for CNS metastasis of ALK rearranged NSCLC | Dong Won Park(Hanyang University) |
[SY09] Lung Cancer- Session Title: New insights and emerging therapies for lung cancer |
Crystal Ballroom 3 | |
15:30-17:00 | Chair: David Chi-Leung Lam(Hong Kong University)Darren Wan-Teck Lim(National Cancer Center Singapore) | |
15:30-16:00 | Therapeutic biomarkers in lung cancer | David Chi-Leung Lam(Hong Kong University) |
16:00-16:30 | Immunotherapy for NSCLC – addressing heterogeneity | Darren Wan-Teck Lim(National Cancer Center Singapore) |
16:30-17:00 | The journey of immuno-oncology; changing landscape for cancer treatment | Natasha Leighl(University of Toronto) |
[SY10] Meet the expert - COPD |
Charlotte | |
10:30-12:00 | ||
10:30-12:00 | ICS use and blood eosinophils in COPD; precision medicine | Dave Singh(University of Manchester) |
[SY11] Meet the expert - Tuberculosis |
Charlotte | |
13:30-15:00 | ||
13:30-15:00 | The role of new drugs for MDR-TB management | Jeffrey S. Hafkin(Otsuka Pharmaceutical Development and Commercialization) |
[SY12] Meet the expert – COPD |
Charlotte | |
15:30-17:00 | ||
15:30-17:00 | Challenging Questions in COPD | Chirstopher Cooper(UCLA Pulmonary Function and Exercise Physiology Research Laboratories) |